GALXC - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Image for trademark with serial number 87315576
Serial Number
87315576
Word Mark
GALXC
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2021-03-22
Filing Date
2017-01-27
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form Typeset
Published for Opposition Date
2017-12-19
Attorney Name
Law Office Assigned Location Code
L10
Employee Name
LORENZO, GEORGE M
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of the term "GALXC" in stylized font with the letter "X" shown in an enlarged image.
Goods and Services
Oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; Oligonucleotide delivery agents for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for a wide range of medical purposes; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
Goods and Services
Custom manufacture of oligonucleotides for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders
Goods and Services
Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-01-31
Primary Code
005
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2017-01-31
Primary Code
040
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2017-01-31
Primary Code
042
Correspondences
Name
Glenn A. Gundersen
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2017-01-31NEW APPLICATION ENTERED IN TRAM
2017-01-31NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2017-04-24ASSIGNED TO EXAMINER
2017-04-25NON-FINAL ACTION WRITTEN
2017-04-25NON-FINAL ACTION E-MAILED
2017-04-25NOTIFICATION OF NON-FINAL ACTION E-MAILED
2017-07-27TEAS RESPONSE TO OFFICE ACTION RECEIVED
2017-07-27CORRESPONDENCE RECEIVED IN LAW OFFICE
2017-07-28TEAS/EMAIL CORRESPONDENCE ENTERED
2017-08-07FINAL REFUSAL WRITTEN
2017-08-07FINAL REFUSAL E-MAILED
2017-08-07NOTIFICATION OF FINAL REFUSAL EMAILED
2017-11-02TEAS REQUEST FOR RECONSIDERATION RECEIVED
2017-11-14ASSIGNED TO LIE
2017-11-15CORRESPONDENCE RECEIVED IN LAW OFFICE
2017-11-15TEAS/EMAIL CORRESPONDENCE ENTERED
2017-11-15APPROVED FOR PUB - PRINCIPAL REGISTER
2017-11-29NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2017-12-19PUBLISHED FOR OPPOSITION
2017-12-19OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2018-02-13NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2018-07-23TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
2018-08-13TEAS EXTENSION RECEIVED
2018-08-13EXTENSION 1 FILED
2018-08-13EXTENSION 1 GRANTED
2018-08-15NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-01-10TEAS EXTENSION RECEIVED
2019-01-10EXTENSION 2 FILED
2019-01-10EXTENSION 2 GRANTED
2019-01-12NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-06-10TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2019-06-10ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2019-08-12TEAS EXTENSION RECEIVED
2019-08-12EXTENSION 3 FILED
2019-08-12EXTENSION 3 GRANTED
2019-08-14NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-02-13TEAS EXTENSION RECEIVED
2020-02-13EXTENSION 4 FILED
2020-02-13EXTENSION 4 GRANTED
2020-02-15NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-06-04ASSIGNED TO EXAMINER
2020-08-12TEAS EXTENSION RECEIVED
2020-08-18CASE ASSIGNED TO INTENT TO USE PARALEGAL
2020-08-12EXTENSION 5 FILED
2020-08-18EXTENSION 5 GRANTED
2020-08-19NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-02-25TEAS CHANGE OF OWNER ADDRESS RECEIVED
2021-02-25TEAS CHANGE OF CORRESPONDENCE RECEIVED
2021-02-25APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2021-03-22ABANDONMENT - NO USE STATEMENT FILED
2021-03-22ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED